Skip to content

Randomized, double-blind, crossover, confirmation test of cold sensitivity and blood flow improving function by ingesting test food.

Randomized, double-blind, crossover, confirmation test of cold sensitivity and blood flow improving function by ingesting test food. - Randomized, double-blind, crossover, confirmation test of cold sensitivity and blood flow improving function by ingesting test food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025798
Enrollment
25
Registered
2017-01-23
Start date
2017-01-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Females in good health

Interventions

Ingesting test food, 2 tablets after completion of morning meal for 2 weeks. After 2 weeks of washout period, ingesting placebo food, 2 tablets in a day for 2 weeks. Ingesting test food, 2 tablets aft

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Females aged over 20 years old when obtaining informed consent. 2) Subjects who have subjective symptoms of cold sensitivity. 3) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1) Subjects who were diagnosed as chilliness by medical doctor. 2) Subjects who ingest medicines and/or supplement regularly for improving fatigue, blood flow, cold sensitivity or stress. 3) Pregnant or possibly pregnant women, or lactating women. 4) Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney and/or digestive trucks. 5) Subjects who excessive alcohol intake. 6) Subjects who have extremely irregular life rhythms, and subjects who have midnight work or irregular shift work. 7) Subjects who have previous medical history of drug and/or food allergy. 8) Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within 4-weeks prior to the current study. 9) Subjects who donated over 200mL blood and/or blood components within a month to the current study. 10) Subjects who donated over 400mL blood within the last four months to the current study. 11) Subjects who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve months are adding to the planned sampling amounts of this study. 12) Subjects who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Body surface temperature and blood flow after 2 weeks ingestion of test food.

Secondary

MeasureTime frame
Blood NOx concentration on 60min after test food ingestion. Questionnaire after 2 weeks ingestion of test food.

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Plan Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026